Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
2,489
Views
4
CrossRef citations to date
0
Altmetric
Coronaviruses
Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Ji-Min Seoa Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0003-2687-7495View further author information
Bobin Kanga Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0002-0551-5391View further author information
Rina Songa Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0003-3036-959XView further author information
Hanmi Noha Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0001-7515-8740View further author information
Cheolmin Kima Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0001-7810-5601View further author information
Jong-In Kima Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0001-7376-1036View further author information
Minsoo Kima Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0003-4394-6528View further author information
Dong-Kyun Ryua Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0003-4237-4740View further author information
Min-Ho Leeb New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea
https://orcid.org/0000-0003-0197-3456View further author information
Jeong-Sun Yangc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Korea
https://orcid.org/0000-0001-5005-9738View further author information
Kyung-Chang Kimc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Korea
https://orcid.org/0000-0002-1075-0804View further author information
Joo-Yeon Leec Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Korea
https://orcid.org/0000-0002-0993-9626View further author information
Hansaem Leec Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Korea
https://orcid.org/0000-0002-9430-8123View further author information
Hye-Min Wooc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Korea
https://orcid.org/0000-0001-8020-3489View further author information
Jun-Won Kimc Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control & Prevention Agency, Cheongju, Republic of Korea
https://orcid.org/0000-0001-9393-4248View further author information
Jung-Ah Choid Science Unit, International Vaccine Institute, Seoul, Republic of Korea
https://orcid.org/0000-0003-2381-7374View further author information
Manki Songd Science Unit, International Vaccine Institute, Seoul, Republic of Korea
https://orcid.org/0000-0002-8279-9041View further author information
Monika Tomaszewska-Kiecanae Biokinetica S.A. Phase 1 Unit, Jozefow, Poland
https://orcid.org/0000-0001-8501-5479View further author information
Anna Wołowike Biokinetica S.A. Phase 1 Unit, Jozefow, Poland
https://orcid.org/0000-0003-2913-948XView further author information
Agnieszka Kuleszae Biokinetica S.A. Phase 1 Unit, Jozefow, Poland
https://orcid.org/0000-0002-0006-9433View further author information
Sunghyun Kima Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0003-3898-0393View further author information
Keumyoung Ahna Celltrion Inc, Incheon, Republic of Korea
https://orcid.org/0000-0002-9370-5338View further author information
Nahyun Junga Celltrion Inc, Incheon, Republic of KoreaView further author information
& Soo-Young Leea Celltrion Inc, Incheon, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-3306-9333View further author information
Pages 2315-2325
|
Received 24 May 2022, Accepted 21 Aug 2022, Published online: 27 Sep 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.